Related Experiment Video
Updated: Apr 23, 2026

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma
Published on: April 3, 2026
An action plan for translating cancer survivorship research into care
Catherine M Alfano1, Tenbroeck Smith2, Janet S de Moor2
1Behavioral Research Program (CMA, CP, LP), Applied Research Program (JSdM), Implementation Science Team (REG), Epidemiology and Genomics Research Program (MJK), and Office of Cancer Survivorship (JHR), Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD; Behavioral Research Center, American Cancer Society, Atlanta, GA (TS, KDS, CRL); Office of Public Health Genomics (MJK) and Division of Cancer Prevention and Control (NAH), Centers for Disease Control and Prevention, Atlanta, GA; LIVESTRONG Foundation, Austin, TX (RR); Present addresses: Department of Family Medicine, University of Colorado, Denver, CO (REG); Department of Research and Evaluation, Kaiser Permanente Research, Pasadena, CA (CP). catherine.alfano@nih.gov.
Abstract:
To meet the complex needs of a growing number of cancer survivors, it is essential to accelerate the translation of survivorship research into evidence-based interventions and, as appropriate, recommendations for care that may be implemented in a wide variety of settings. Current progress in translating research into care is stymied, with results of many studies un- or underutilized. To better understand this problem and identify strategies to encourage the translation of survivorship research findings into practice, four agencies (American Cancer Society, Centers for Disease Control and Prevention, LIVE STRONG: Foundation, National Cancer Institute) hosted a meeting in June, 2012, titled: "Biennial Cancer Survivorship Research Conference: Translating Science to Care." Meeting participants concluded that accelerating science into care will require a coordinated, collaborative effort by individuals from diverse settings, including researchers and clinicians, survivors and families, public health professionals, and policy makers. This commentary describes an approach stemming from that meeting to facilitate translating research into care by changing the process of conducting research-improving communication, collaboration, evaluation, and feedback through true and ongoing partnerships. We apply the T0-T4 translational process model to survivorship research and provide illustrations of its use. The resultant framework is intended to orient stakeholders to the role of their work in the translational process and facilitate the transdisciplinary collaboration needed to translate basic discoveries into best practices regarding clinical care, self-care/management, and community programs for cancer survivors. Finally, we discuss barriers to implementing translational survivorship science identified at the meeting, along with future directions to accelerate this process.
Related Concept Videos
Cancer Survival Analysis
Treatment Resistant Cancers
Cancer Therapies
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...